246 related articles for article (PubMed ID: 28403785)
1. Apoptotic Effects of Some Tetrahydronaphthalene Derivatives on K562 Human Chronic Myelogenous Leukemia Cell Line.
Koc A; Ozkan T; Hekmatshoar Y; Gurkan-Alp AS; Aktan F; Buyukbingol Z; Sunguroglu A; Buyukbingol E; Karabay AZ
Anticancer Agents Med Chem; 2018 Feb; 17(14):1924-1930. PubMed ID: 28403785
[TBL] [Abstract][Full Text] [Related]
2. Quercetin Promotes Cell Cycle Arrest and Apoptosis and Attenuates the Proliferation of Human Chronic Myeloid Leukemia Cell Line-K562 Through Interaction with HSPs (70 and 90), MAT2A and FOXM1.
Hassanzadeh A; Hosseinzadeh E; Rezapour S; Vahedi G; Haghnavaz N; Marofi F
Anticancer Agents Med Chem; 2019; 19(12):1523-1534. PubMed ID: 31362681
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.
Xin P; Li C; Zheng Y; Peng Q; Xiao H; Huang Y; Zhu X
Drug Des Devel Ther; 2017; 11():1115-1126. PubMed ID: 28435223
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anticancer effects of some novel 2-(4-phenoxyphenyl)-1H-benzimidazole derivatives on K562 cell line.
Gurkan-Alp AS; Göker H; Alp M; Ozkan T; Sunguroglu A
Arch Pharm Res; 2015; 38(5):650-8. PubMed ID: 25030856
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis and erythroid differentiation of human chronic myelogenous leukemia K562 cells by low concentrations of lidamycin.
Zhang C; Guo LY; Mu D; Gong JH; Chen J
Oncol Rep; 2019 Jan; 41(1):475-482. PubMed ID: 30542729
[TBL] [Abstract][Full Text] [Related]
6. [Apoptosis mechanism in human chronic myelogenous leukemia K562 cells induced by tetra-arsenic tetra-sulfide].
Ye QD; Gu LJ; Zhao YX; Zhao JC; Chen WG; Zhang B; Jiang LM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):759-63. PubMed ID: 16277837
[TBL] [Abstract][Full Text] [Related]
7. Hydroxy Cinnamic Acid Derivatives as Partial PPARγ Agonists: In silico Studies, Synthesis and Biological Characterization Against Chronic Myeloid Leukemia Cell Line (K562).
Joshi H; Marulkar K; Gota V; Ramaa CS
Anticancer Agents Med Chem; 2017; 17(4):524-541. PubMed ID: 27291250
[TBL] [Abstract][Full Text] [Related]
8. The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway.
Wei YL; Liang Y; Xu L; Zhao XY
Anat Rec (Hoboken); 2009 Jul; 292(7):945-50. PubMed ID: 19548306
[TBL] [Abstract][Full Text] [Related]
9. Spiroquinazolinone-induced cytotoxicity and apoptosis in K562 human leukemia cells: alteration in expression levels of Bcl-2 and Bax.
Ghasemian M; Mahdavi M; Zare P; Ali Hosseinpour Feizi M
J Toxicol Sci; 2015 Feb; 40(1):115-26. PubMed ID: 25743751
[TBL] [Abstract][Full Text] [Related]
10. Novel indole retinoid derivative induces apoptosis and cell cycle arrest and modulates AKT and ERK signaling in HL-60 cells.
Gurkan-Alp AS; Karabay AZ; Koc A; Buyukbingol E
Fundam Clin Pharmacol; 2023 Jun; 37(3):557-565. PubMed ID: 36690337
[TBL] [Abstract][Full Text] [Related]
11. Anti-leukemic effects of gallic acid on human leukemia K562 cells: downregulation of COX-2, inhibition of BCR/ABL kinase and NF-κB inactivation.
Chandramohan Reddy T; Bharat Reddy D; Aparna A; Arunasree KM; Gupta G; Achari C; Reddy GV; Lakshmipathi V; Subramanyam A; Reddanna P
Toxicol In Vitro; 2012 Apr; 26(3):396-405. PubMed ID: 22245431
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of Survivin and Bcl-2 concomitant with the activation of caspase-3 as a mechanism of apoptotic death in KG1a and K562 cells upon exposure to a derivative from ciprofloxacin family.
Eslami F; Mahdavi M; Babaei E; Hussen BM; Mostafavi H; Shahbazi A; Hidayat HJ
Toxicol Appl Pharmacol; 2020 Dec; 409():115331. PubMed ID: 33171188
[TBL] [Abstract][Full Text] [Related]
13. In Vitro Anticancer Effects of Two New Potent Hydrazide Compounds on Leukemic Cells.
Tavakolfar S; Mousavi E; Almasirad A; Amanzadeh A; Atyabi SM; Yaghamii P; Samiee-Sadr S; Salimi M
Anticancer Agents Med Chem; 2016; 16(12):1646-1651. PubMed ID: 27039920
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor activity of emodin against human chronic myelocytic leukemia K562 cell lines in vitro and in vivo.
Chun-Guang W; Jun-Qing Y; Bei-Zhong L; Dan-Ting J; Chong W; Liang Z; Dan Z; Yan W
Eur J Pharmacol; 2010 Feb; 627(1-3):33-41. PubMed ID: 19857484
[TBL] [Abstract][Full Text] [Related]
15. ITR‑284 modulates cell differentiation in human chronic myelogenous leukemia K562 cells.
Yang JS; Lee CY; Cho HC; Lu CC; Kuo SC; Wen YF; Tsai FJ; Lee MR; Tsai SC
Oncol Rep; 2018 Jan; 39(1):383-391. PubMed ID: 29138846
[TBL] [Abstract][Full Text] [Related]
16. A derivative of epigallocatechin-3-gallate induces apoptosis via SHP-1-mediated suppression of BCR-ABL and STAT3 signalling in chronic myelogenous leukaemia.
Jung JH; Yun M; Choo EJ; Kim SH; Jeong MS; Jung DB; Lee H; Kim EO; Kato N; Kim B; Srivastava SK; Kaihatsu K; Kim SH
Br J Pharmacol; 2015 Jul; 172(14):3565-78. PubMed ID: 25825203
[TBL] [Abstract][Full Text] [Related]
17. Armillaridin induces autophagy-associated cell death in human chronic myelogenous leukemia K562 cells.
Chang WH; Huang HL; Huang WP; Chen CC; Chen YJ
Tumour Biol; 2016 Oct; 37(10):14291-14300. PubMed ID: 27592257
[TBL] [Abstract][Full Text] [Related]
18. Dual induction of mitochondrial apoptosis and senescence in chronic myelogenous leukemia by myrtucommulone A.
Grandjenette C; Schnekenburger M; Morceau F; Mack F; Wiechmann K; Werz O; Dicato M; Diederich M
Anticancer Agents Med Chem; 2015; 15(3):363-73. PubMed ID: 25469628
[TBL] [Abstract][Full Text] [Related]
19. A Novel Methoxybenzyl 5-Nitroacridone Derivative Effectively Triggers G1 Cell Cycle Arrest in Chronic Myelogenous Leukemia K562 Cells by Inhibiting CDK4/6-Mediated Phosphorylation of Rb.
Zhang B; Zhang T; Zhang TY; Wang N; He S; Wu B; Jin HX
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708403
[TBL] [Abstract][Full Text] [Related]
20. Saponins from Rubus parvifolius L. induce apoptosis in human chronic myeloid leukemia cells through AMPK activation and STAT3 inhibition.
Ge YQ; Xu XF; Yang B; Chen Z; Cheng RB
Asian Pac J Cancer Prev; 2014; 15(13):5455-61. PubMed ID: 25041018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
